CN Stock MarketDetailed Quotes

300142 Walvax Biotechnology

Watchlist
  • 14.96
  • -0.63-4.04%
Trading Nov 18 14:45 CST
23.93BMarket Cap194.29P/E (TTM)

Walvax Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-32.19%2.14B
-33.88%1.43B
-28.02%599.75M
-19.12%4.11B
-14.79%3.16B
-7.68%2.17B
27.04%833.27M
46.89%5.09B
74.06%3.71B
73.96%2.35B
Operating revenue
-32.19%2.14B
-33.88%1.43B
-28.02%599.75M
-19.12%4.11B
-14.79%3.16B
-7.68%2.17B
27.04%833.27M
46.89%5.09B
74.06%3.71B
73.96%2.35B
Other operating revenue
----
314.92%13.71M
----
3.51%7.92M
----
-40.96%3.3M
----
-27.15%7.65M
----
8.83%5.6M
Total operating cost
-24.34%1.76B
-22.77%1.18B
-30.14%462.15M
-17.18%3.15B
-15.59%2.32B
-9.79%1.53B
27.85%661.54M
44.85%3.81B
76.83%2.75B
72.20%1.69B
Operating cost
-2.36%440.62M
5.20%286.73M
-9.07%113.52M
-1.95%597.56M
3.88%451.26M
-6.92%272.57M
64.36%124.85M
54.55%609.47M
60.86%434.39M
76.23%292.83M
Operating tax surcharges
-45.86%13.74M
-52.60%9.34M
-64.08%4.17M
-3.68%32.03M
1.09%25.37M
50.32%19.71M
134.35%11.62M
67.71%33.25M
96.91%25.1M
60.98%13.11M
Operating expense
-40.46%680.7M
-36.12%500.22M
-31.01%210.46M
-24.85%1.52B
-22.78%1.14B
-13.33%783.05M
18.70%305.03M
51.93%2.02B
94.64%1.48B
80.97%903.5M
Administration expense
21.75%219.91M
1.88%123.17M
6.10%61.79M
9.65%297.62M
-2.72%180.63M
6.17%120.9M
6.59%58.23M
-9.44%271.42M
-8.10%185.68M
-17.15%113.87M
Financial expense
43.50%-30.05M
21.26%-27.77M
13.44%-14.8M
-12.72%-70.99M
1.10%-53.19M
-10.75%-35.26M
-20.32%-17.1M
-62.65%-62.98M
-105.73%-53.78M
-98.79%-31.84M
-Interest expense (Financial expense)
104.32%7.68M
133.17%6.35M
164.41%3.38M
-16.30%5.95M
-31.83%3.76M
-26.11%2.72M
-57.67%1.28M
23.15%7.11M
38.49%5.51M
58.42%3.69M
-Interest Income (Financial expense)
12.24%-46.21M
8.69%-33.11M
-3.64%-18.31M
-6.01%-74.23M
-2.19%-52.66M
-5.98%-36.26M
-3.47%-17.67M
-54.19%-70.03M
-70.35%-51.53M
-83.52%-34.21M
Research and development
-24.82%431.11M
-21.42%286.96M
-51.36%87.02M
-16.77%776.43M
-15.34%573.44M
-8.77%365.19M
28.61%178.91M
50.11%932.89M
101.94%677.34M
113.50%400.31M
Credit Impairment Loss
161.51%41.26M
196.73%58.69M
-1,402.83%-9.89M
-92.81%-88.52M
-186,850.31%-67.08M
-1,587.95%-60.68M
-254.44%-658.31K
-216.11%-45.91M
99.76%-35.88K
575.49%4.08M
Asset Impairment Loss
-681.19%-98.21M
-1,774.78%-67.34M
-8.55%-7.61M
-164.60%-162.64M
57.44%-12.57M
71.30%-3.59M
-870.11%-7.01M
-418.91%-61.47M
-423.77%-29.54M
-19.10%-12.51M
Other net revenue
-71.49%-99.23M
-599.75%-66.28M
-282.35%-77.95M
-92.27%-347.59M
54.69%-57.86M
76.38%-9.47M
193.47%42.75M
-44.72%-180.78M
-1,086.84%-127.72M
-140.44%-40.1M
Fair value change income
-39.03%-93.69M
-477.86%-102.01M
-7,010.23%-84.82M
-17.77%-234.75M
68.31%-67.39M
75.39%-17.65M
98.52%-1.19M
29.00%-199.33M
-125.78%-212.64M
-511.82%-71.73M
Invest income
-22.20%4.9M
-42.25%3.65M
132.44%86.84K
-39.69%7.11M
30.18%6.29M
1,266.22%6.33M
-76.86%-267.7K
-79.62%11.8M
-91.68%4.84M
-100.93%-542.64K
-Including: Investment income associates
117.09%74.82K
100.32%1.31K
140.26%86.84K
135.58%382.09K
34.76%-437.76K
25.55%-404.02K
-42.50%-215.69K
-15.18%-1.07M
7.70%-670.98K
-38.60%-542.64K
Asset deal income
80.67%-111.1K
-162.80%-108.16K
----
-116.55%-827.73K
-1,703.04%-574.86K
--172.21K
--172.21K
-265.55%-382.24K
-116.58%-31.88K
----
Other revenue
-44.14%46.62M
-38.08%40.83M
-53.05%24.28M
15.30%132.03M
-23.91%83.46M
62.40%65.95M
47.44%51.7M
63.55%114.51M
141.19%109.69M
23.01%40.61M
Operating profit
-63.29%286.08M
-70.19%188.42M
-72.19%59.65M
-44.16%613.97M
-6.00%779.31M
2.58%632.06M
131.30%214.48M
54.79%1.1B
47.10%829.07M
32.11%616.16M
Add:Non operating Income
13,501.19%126.92M
13,799.10%126.92M
-99.79%101.88
619.41%935.06K
1,413.66%933.18K
1,242.62%913.18K
231.12%48.85K
-95.02%129.98K
-97.13%61.65K
-96.78%68.02K
Less:Non operating expense
551.05%39.22M
661.34%37.65M
-36.87%2.4M
-45.28%15.92M
-74.18%6.02M
-70.10%4.94M
-58.74%3.8M
638.26%29.1M
694.08%23.33M
452.91%16.54M
Total profit
-51.72%373.79M
-55.78%277.69M
-72.83%57.25M
-44.05%598.98M
-3.92%774.22M
4.72%628.02M
152.24%210.73M
50.99%1.07B
43.17%805.8M
28.82%599.7M
Less:Income tax cost
-69.93%23.15M
-69.18%20.18M
52.41%18.94M
-33.72%87.65M
-34.25%76.99M
-32.99%65.47M
-26.00%12.43M
22.91%132.24M
49.40%117.1M
68.46%97.7M
Net profit
-49.71%350.64M
-54.22%257.52M
-80.68%38.31M
-45.50%511.33M
1.24%697.23M
12.06%562.55M
197.09%198.3M
56.02%938.23M
42.16%688.7M
23.17%501.99M
Net profit from continuing operation
-49.71%350.64M
-54.22%257.52M
-80.68%38.31M
-45.50%511.33M
1.24%697.23M
12.06%562.55M
197.09%198.3M
56.02%938.23M
42.16%688.7M
23.17%501.99M
Less:Minority Profit
-34.46%94.28M
-18.97%86.96M
-8.09%24.18M
-56.13%91.93M
-8.55%143.85M
32.50%107.31M
-6.45%26.31M
20.72%209.57M
31.00%157.31M
-8.34%80.99M
Net profit of parent company owners
-53.67%256.36M
-62.53%170.56M
-91.79%14.13M
-42.44%419.39M
4.14%553.38M
8.13%455.24M
345.34%171.99M
70.35%728.65M
45.84%531.39M
31.90%421.01M
Earning per share
Basic earning per share
-53.64%0.1603
-62.52%0.1066
-91.81%0.0088
-42.34%0.2621
2.40%0.3458
8.18%0.2844
345.64%0.1074
66.70%0.4546
44.69%0.3377
28.37%0.2629
Diluted earning per share
-53.64%0.1603
-62.52%0.1066
-91.81%0.0088
-42.32%0.2621
2.49%0.3458
8.38%0.2844
345.64%0.1074
67.12%0.4544
45.62%0.3374
30.16%0.2624
Other composite income
-96.66%850K
Other composite income of parent company owners
----
----
----
----
----
----
----
-96.66%850K
----
----
Total composite income
-49.71%350.64M
-54.22%257.52M
-80.68%38.31M
-45.55%511.33M
1.24%697.23M
12.06%562.55M
197.09%198.3M
49.82%939.08M
42.16%688.7M
23.17%501.99M
Total composite income of parent company owners
-53.67%256.36M
-62.53%170.56M
-91.79%14.13M
-42.51%419.39M
4.14%553.38M
8.13%455.24M
345.34%171.99M
60.97%729.5M
45.84%531.39M
31.90%421.01M
Total composite income of minority owners
-34.46%94.28M
-18.97%86.96M
-8.09%24.18M
-56.13%91.93M
-8.55%143.85M
32.50%107.31M
-6.45%26.31M
20.72%209.57M
31.00%157.31M
-8.34%80.99M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -32.19%2.14B-33.88%1.43B-28.02%599.75M-19.12%4.11B-14.79%3.16B-7.68%2.17B27.04%833.27M46.89%5.09B74.06%3.71B73.96%2.35B
Operating revenue -32.19%2.14B-33.88%1.43B-28.02%599.75M-19.12%4.11B-14.79%3.16B-7.68%2.17B27.04%833.27M46.89%5.09B74.06%3.71B73.96%2.35B
Other operating revenue ----314.92%13.71M----3.51%7.92M-----40.96%3.3M-----27.15%7.65M----8.83%5.6M
Total operating cost -24.34%1.76B-22.77%1.18B-30.14%462.15M-17.18%3.15B-15.59%2.32B-9.79%1.53B27.85%661.54M44.85%3.81B76.83%2.75B72.20%1.69B
Operating cost -2.36%440.62M5.20%286.73M-9.07%113.52M-1.95%597.56M3.88%451.26M-6.92%272.57M64.36%124.85M54.55%609.47M60.86%434.39M76.23%292.83M
Operating tax surcharges -45.86%13.74M-52.60%9.34M-64.08%4.17M-3.68%32.03M1.09%25.37M50.32%19.71M134.35%11.62M67.71%33.25M96.91%25.1M60.98%13.11M
Operating expense -40.46%680.7M-36.12%500.22M-31.01%210.46M-24.85%1.52B-22.78%1.14B-13.33%783.05M18.70%305.03M51.93%2.02B94.64%1.48B80.97%903.5M
Administration expense 21.75%219.91M1.88%123.17M6.10%61.79M9.65%297.62M-2.72%180.63M6.17%120.9M6.59%58.23M-9.44%271.42M-8.10%185.68M-17.15%113.87M
Financial expense 43.50%-30.05M21.26%-27.77M13.44%-14.8M-12.72%-70.99M1.10%-53.19M-10.75%-35.26M-20.32%-17.1M-62.65%-62.98M-105.73%-53.78M-98.79%-31.84M
-Interest expense (Financial expense) 104.32%7.68M133.17%6.35M164.41%3.38M-16.30%5.95M-31.83%3.76M-26.11%2.72M-57.67%1.28M23.15%7.11M38.49%5.51M58.42%3.69M
-Interest Income (Financial expense) 12.24%-46.21M8.69%-33.11M-3.64%-18.31M-6.01%-74.23M-2.19%-52.66M-5.98%-36.26M-3.47%-17.67M-54.19%-70.03M-70.35%-51.53M-83.52%-34.21M
Research and development -24.82%431.11M-21.42%286.96M-51.36%87.02M-16.77%776.43M-15.34%573.44M-8.77%365.19M28.61%178.91M50.11%932.89M101.94%677.34M113.50%400.31M
Credit Impairment Loss 161.51%41.26M196.73%58.69M-1,402.83%-9.89M-92.81%-88.52M-186,850.31%-67.08M-1,587.95%-60.68M-254.44%-658.31K-216.11%-45.91M99.76%-35.88K575.49%4.08M
Asset Impairment Loss -681.19%-98.21M-1,774.78%-67.34M-8.55%-7.61M-164.60%-162.64M57.44%-12.57M71.30%-3.59M-870.11%-7.01M-418.91%-61.47M-423.77%-29.54M-19.10%-12.51M
Other net revenue -71.49%-99.23M-599.75%-66.28M-282.35%-77.95M-92.27%-347.59M54.69%-57.86M76.38%-9.47M193.47%42.75M-44.72%-180.78M-1,086.84%-127.72M-140.44%-40.1M
Fair value change income -39.03%-93.69M-477.86%-102.01M-7,010.23%-84.82M-17.77%-234.75M68.31%-67.39M75.39%-17.65M98.52%-1.19M29.00%-199.33M-125.78%-212.64M-511.82%-71.73M
Invest income -22.20%4.9M-42.25%3.65M132.44%86.84K-39.69%7.11M30.18%6.29M1,266.22%6.33M-76.86%-267.7K-79.62%11.8M-91.68%4.84M-100.93%-542.64K
-Including: Investment income associates 117.09%74.82K100.32%1.31K140.26%86.84K135.58%382.09K34.76%-437.76K25.55%-404.02K-42.50%-215.69K-15.18%-1.07M7.70%-670.98K-38.60%-542.64K
Asset deal income 80.67%-111.1K-162.80%-108.16K-----116.55%-827.73K-1,703.04%-574.86K--172.21K--172.21K-265.55%-382.24K-116.58%-31.88K----
Other revenue -44.14%46.62M-38.08%40.83M-53.05%24.28M15.30%132.03M-23.91%83.46M62.40%65.95M47.44%51.7M63.55%114.51M141.19%109.69M23.01%40.61M
Operating profit -63.29%286.08M-70.19%188.42M-72.19%59.65M-44.16%613.97M-6.00%779.31M2.58%632.06M131.30%214.48M54.79%1.1B47.10%829.07M32.11%616.16M
Add:Non operating Income 13,501.19%126.92M13,799.10%126.92M-99.79%101.88619.41%935.06K1,413.66%933.18K1,242.62%913.18K231.12%48.85K-95.02%129.98K-97.13%61.65K-96.78%68.02K
Less:Non operating expense 551.05%39.22M661.34%37.65M-36.87%2.4M-45.28%15.92M-74.18%6.02M-70.10%4.94M-58.74%3.8M638.26%29.1M694.08%23.33M452.91%16.54M
Total profit -51.72%373.79M-55.78%277.69M-72.83%57.25M-44.05%598.98M-3.92%774.22M4.72%628.02M152.24%210.73M50.99%1.07B43.17%805.8M28.82%599.7M
Less:Income tax cost -69.93%23.15M-69.18%20.18M52.41%18.94M-33.72%87.65M-34.25%76.99M-32.99%65.47M-26.00%12.43M22.91%132.24M49.40%117.1M68.46%97.7M
Net profit -49.71%350.64M-54.22%257.52M-80.68%38.31M-45.50%511.33M1.24%697.23M12.06%562.55M197.09%198.3M56.02%938.23M42.16%688.7M23.17%501.99M
Net profit from continuing operation -49.71%350.64M-54.22%257.52M-80.68%38.31M-45.50%511.33M1.24%697.23M12.06%562.55M197.09%198.3M56.02%938.23M42.16%688.7M23.17%501.99M
Less:Minority Profit -34.46%94.28M-18.97%86.96M-8.09%24.18M-56.13%91.93M-8.55%143.85M32.50%107.31M-6.45%26.31M20.72%209.57M31.00%157.31M-8.34%80.99M
Net profit of parent company owners -53.67%256.36M-62.53%170.56M-91.79%14.13M-42.44%419.39M4.14%553.38M8.13%455.24M345.34%171.99M70.35%728.65M45.84%531.39M31.90%421.01M
Earning per share
Basic earning per share -53.64%0.1603-62.52%0.1066-91.81%0.0088-42.34%0.26212.40%0.34588.18%0.2844345.64%0.107466.70%0.454644.69%0.337728.37%0.2629
Diluted earning per share -53.64%0.1603-62.52%0.1066-91.81%0.0088-42.32%0.26212.49%0.34588.38%0.2844345.64%0.107467.12%0.454445.62%0.337430.16%0.2624
Other composite income -96.66%850K
Other composite income of parent company owners -----------------------------96.66%850K--------
Total composite income -49.71%350.64M-54.22%257.52M-80.68%38.31M-45.55%511.33M1.24%697.23M12.06%562.55M197.09%198.3M49.82%939.08M42.16%688.7M23.17%501.99M
Total composite income of parent company owners -53.67%256.36M-62.53%170.56M-91.79%14.13M-42.51%419.39M4.14%553.38M8.13%455.24M345.34%171.99M60.97%729.5M45.84%531.39M31.90%421.01M
Total composite income of minority owners -34.46%94.28M-18.97%86.96M-8.09%24.18M-56.13%91.93M-8.55%143.85M32.50%107.31M-6.45%26.31M20.72%209.57M31.00%157.31M-8.34%80.99M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Daxin Certified Public Accountants (Special General Partnership)------Daxin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data